Detalles de la búsqueda
1.
Pathological complete response rates following different neoadjuvant chemotherapy regimens for operable breast cancer according to ER status, in two parallel, randomized phase II trials with an adaptive study design (ECTO II).
Breast Cancer Res Treat
; 132(3): 843-51, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21750964
2.
A New Genetic Risk Score to Predict the Outcome of Locally Advanced or Metastatic Breast Cancer Patients Treated With First-Line Exemestane: Results From a Prospective Study.
Clin Breast Cancer
; 19(2): 137-145.e4, 2019 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-30584056
3.
A liquid chromatography-tandem mass spectrometry method for the simultaneous determination of exemestane and its metabolite 17-dihydroexemestane in human plasma.
J Mass Spectrom
; 44(6): 920-8, 2009 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-19214962
4.
Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis.
Breast Cancer Res Treat
; 101(3): 279-84, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16835704
5.
The impact of progenitor enrichment, serum, and cytokines on the ex vivo expansion of mobilized peripheral blood stem cells: a controlled trial.
Stem Cells
; 21(1): 33-40, 2003.
Artículo
en Inglés
| MEDLINE | ID: mdl-12529549
6.
Human fibroblasts from normal and malignant breast tissue grown in vitro show a distinct senescence profile and telomerase activity.
Histochem J
; 34(8-9): 403-10, 2002.
Artículo
en Inglés
| MEDLINE | ID: mdl-12814188
Resultados
1 -
6
de 6
1
Próxima >
>>